Zoetis (BSP:Z1TS34) Current Accrued Expense : R$3,347 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Zoetis Current Accrued Expense?

Zoetis's Current Accrued Expense for the quarter that ended in Dec. 2023 was R$3,347 Mil.

Zoetis's quarterly Current Accrued Expense increased from Jun. 2023 (R$3,344 Mil) to Sep. 2023 (R$3,423 Mil) but then declined from Sep. 2023 (R$3,423 Mil) to Dec. 2023 (R$3,347 Mil).

Zoetis's annual Current Accrued Expense declined from Dec. 2021 (R$4,015 Mil) to Dec. 2022 (R$3,577 Mil) and declined from Dec. 2022 (R$3,577 Mil) to Dec. 2023 (R$3,347 Mil).

Zoetis Current Accrued Expense Historical Data

The historical data trend for Zoetis's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Current Accrued Expense Chart

Zoetis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

2,228.74

2,860.45

4,014.98

3,577.36

3,346.56

Zoetis Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial															3,577.36	3,651.23	3,344.20	3,422.52	3,346.56

Zoetis Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Zoetis Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Zoetis's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Zoetis (BSP:Z1TS34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (BSP:Z1TS34) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

ZTS:USA ZTS:Mexico 1ZTS:Italy ZOE:Germany

Address

10 Sylvan Way, Parsippany, NJ, USA, 07054

Website

https://www.zoetis.com

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis (BSP:Z1TS34) Headlines

No Headlines